-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 7, 2021, Corning Jereh Biopharmaceuticals (stock code: 9966.
Pancreatic cancer is recognized as the "king of cancer" in the medical field.
This phase II clinical study in China enrolled patients with unresectable locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC) confirmed by histology or cytology, with an ECOG PS of 0-1.
As of January 15, 2021, a total of 17 patients were enrolled, the median age (range) was 56 (36-75) years, 9 patients had an ECOG PS score of 1, and 7 patients had liver metastases at baseline
Note: The original text has been deleted